PT  - JOURNAL ARTICLE
AU  - Helwick, Caroline
ED  - Monk, Bradley J.
TI  - Evaluation of Doublet Chemotherapy Regimens for Advanced Cervical Cancer
DP  - 2008 Aug 01
TA  - MD Conference Express
PG  - 12--13
VI  - 8
IP  - 4
4099  - http://mdc.sagepub.com/content/8/4/12.2.short
4100  - http://mdc.sagepub.com/content/8/4/12.2.full
AB  - The results of several Gynecologic Oncology Group (GOG) trials have established doublet chemotherapy with standard-dose cisplatin and paclitaxel as the preferred treatment for advanced or recurrent cervical cancer. The GOG 204 trial [NCT00064077] was conducted to evaluate 3 experimental cisplatin-containing doublet chemotherapy regimens against the standard of cisplatin and paclitaxel.